YF-VAX 1 dose vials
Ended Awarded Last action
- Contract number
- SPE2DR26FBPDZ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,182
Award facts
- Contract value 100% obligated
- $25,181.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX (Yellow Fever Vaccine) 1-dose vials valued at $25,181.60. The delivery order, issued on December 19, 2025, is structured as a firm fixed-price contract with an ultimate completion date of January 13, 2026, and carries no set-aside designation. This award leverages DMS Pharmaceutical Group's established capacity as a critical supplier within the federal pharmaceutical supply chain, demonstrating the company's competitive capability in unrestricted federal procurement.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR. The underlying IDC, awarded on November 13, 2025, carries a $499.999 billion ceiling value and extends through December 31, 2036, positioning DMS Pharmaceutical Group as one of multiple regional prime vendor contractors within the broader $30.3 billion PPV-G GEN V acquisition strategy. The PPV-G GEN V program authorizes DLA to issue delivery orders for comprehensive pharmaceutical and medical supply needs to support Department of Defense healthcare operations globally, with DMS Pharmaceutical Group's established performance across numerous product categories demonstrating its capability to fulfill the diverse and specialized requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FBPDZ?
SPE2DR26FBPDZ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 19, 2025.
How much is contract SPE2DR26FBPDZ worth?
The government has obligated $25,182 on SPE2DR26FBPDZ.
Is contract SPE2DR26FBPDZ an order under another contract?
Yes. SPE2DR26FBPDZ is a delivery order under SPE2DR25D9302, an indefinite delivery contract.
Was contract SPE2DR26FBPDZ competed?
The extent of competition for SPE2DR26FBPDZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award